Analyst Ratings for Karuna Therapeutics Inc. (KRTX)

KRTX Rating Summary

  |   Expand Research on KRTX
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 3.3 / 10   Percentile Rank: 30%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
1/26/2024 Mizuho Vamil Divan Downgrade Neutral
(Outperform)		 330.00
(245.00)		 315.15
(329.83)		 4.66% Details
12/28/2023 JPMorgan Jessica Fye Downgrade Neutral
(Overweight)		 330.00
(217.00)		 317.00
(329.83)		 4.05% Details